Emanuelli Research and Development Center

Arecibo X00612

1 studies enrolling now · 6 studies all time

What they study most

Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Diabetic Macular Edema, Diabetic Retinopathy, Geographic Atrophy, Geographic Atrophy (GA), Hemi-retinal Vein Occlusion, Neovascular Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Retinal Vein Occlusion

Studies at this site

• Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants — Recruiting now
• A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products — Running, not enrolling
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME) — Running, not enrolling
• A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME) — Running, not enrolling
• 4D-150 in Patients With Diabetic Macular Edema — Running, not enrolling
• Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed